CRO Offers Integrated Product Development for Inhaled Dosage Forms
Stuart Needleman, President and Chief Operating Officer, Aptuit, has announced that Aptuit provides integrated product development of inhaled dosage forms through its Chemistry Manufacture and Control (CMC) group located at The Aptuit Center for... more »
Mar 4, 2013 in Ingredients & Contract Services